US Patent 7884244 Therapeutic fluoroethylcyano guanidines
Patent 7884244 was granted and assigned to Allergan, Inc. on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+60 characters)
Article
Patent abstract
Disclosed herein is compound having a formula
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Daniel W. Gil0
Evelyn G. Corpuz0
Ken Chow0
Michael E. Garst0
Wenkui K. Fang0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07884244 Therapeutic fluoroethylcyano guanidines US Patent 7884244 Therapeutic fluoroethylcyano guanidines
Infobox
Patent Number
078842440
Patent Number
78842440
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078842440
Date of Patent
February 8, 2011
0Patent Application Number
120580370
Date Filed
March 28, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07884244 Therapeutic fluoroethylcyano guanidines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07884244
Date of patent
February 8, 2011
Patent application number
12058037
Date Filed
March 28, 2008
Patent primary examiner
Find more entities like US Patent 7884244 Therapeutic fluoroethylcyano guanidines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
